1	Thiol	Thiol	_	_	_	_	_	_	_
2	modulation	modulation	_	_	_	_	_	_	_
3	inhibits	inhibit	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	interleukin	interleukin	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	IL)-1-mediated	il)-1-mediated	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	IL-1	il-1	_	_	_	_	_	_	_
12	receptor-associated	receptor-associated	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	kinase	kinase	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	NF-kappa	NF-kappa	_	_	_	_	_	_	_
17	B.	B.	_	_	_	_	_	_	_
18	The	the	_	_	_	_	_	_	_
19	interleukin-1	interleukin-1	_	_	_	_	_	_	_
20	receptor	receptor	_	_	_	_	_	_	_
21	type	type	_	_	_	_	_	_	_
22	I	i	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	IL-1RI	IL-1RI	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	is	be	_	_	_	_	_	_	_
27	associated	associate	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	other	other	_	_	_	_	_	_	_
30	proteins	protein	_	_	_	_	_	_	_
31	thus	thus	_	_	_	_	_	_	_
32	forming	form	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	complex	complex	_	_	_	_	_	_	_
35	system	system	_	_	_	_	_	_	_
36	by	by	_	_	_	_	_	_	_
37	which	which	_	_	_	_	_	_	_
38	IL-1	il-1	_	_	_	_	_	_	_
39	exerts	exert	_	_	_	_	_	_	_
40	its	its	_	_	_	_	_	_	_
41	various	various	_	_	_	_	_	_	_
42	signals	signal	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	initiating	initiate	_	_	_	_	_	_	_
3	event	event	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	still	still	_	_	_	_	_	_	_
6	uncertain	uncertain	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	but	but	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	recently	recently	_	_	_	_	_	_	_
13	described	describe	_	_	_	_	_	_	_
14	receptor-associated	receptor-associated	_	_	_	_	_	_	_
15	protein	protein	_	_	_	_	_	_	_
16	kinase	kinase	_	_	_	_	_	_	_
17	is	be	_	_	_	_	_	_	_
18	one	one	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	earliest	early	_	_	_	_	_	_	_
22	events	event	_	_	_	_	_	_	_
23	detectable	detectable	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	Martin	Martin	_	_	_	_	_	_	_
26	et	et	_	_	_	_	_	_	_
27	al.	al.	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	Eur.J.Immunol.1994.24	Eur.J.Immunol.1994.24	_	_	_	_	_	_	_
30	:	:	_	_	_	_	_	_	_
31	1566	1566	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	IL-1	il-1	_	_	_	_	_	_	_
2	signaling	signaling	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	commonly	commonly	_	_	_	_	_	_	_
5	accompanied	accompany	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	oxidative	oxidative	_	_	_	_	_	_	_
8	processes	process	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	thought	think	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	be	be	_	_	_	_	_	_	_
14	subject	subject	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	redox	redox	_	_	_	_	_	_	_
17	regulation	regulation	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	therefore	therefore	_	_	_	_	_	_	_
3	investigated	investigate	_	_	_	_	_	_	_
4	whether	whether	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	IL-1RI-associated	il-1ri-associated	_	_	_	_	_	_	_
10	protein	protein	_	_	_	_	_	_	_
11	kinase	kinase	_	_	_	_	_	_	_
12	could	could	_	_	_	_	_	_	_
13	be	be	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	target	target	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	redox	redox	_	_	_	_	_	_	_
18	regulation	regulation	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	whether	whether	_	_	_	_	_	_	_
21	an	an	_	_	_	_	_	_	_
22	altered	altered	_	_	_	_	_	_	_
23	activity	activity	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	kinase	kinase	_	_	_	_	_	_	_
27	could	could	_	_	_	_	_	_	_
28	influence	influence	_	_	_	_	_	_	_
29	IL-1-mediated	il-1-mediated	_	_	_	_	_	_	_
30	NF-kappa	NF-kappa	_	_	_	_	_	_	_
31	B	B	_	_	_	_	_	_	_
32	activation	activation	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	murine	murine	_	_	_	_	_	_	_
3	T	t	_	_	_	_	_	_	_
4	cell	cell	_	_	_	_	_	_	_
5	line	line	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	EL4	EL4	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	stimulated	stimulate	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	IL-1	il-1	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	without	without	_	_	_	_	_	_	_
16	pretreatment	pretreatment	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	different	different	_	_	_	_	_	_	_
19	compounds	compound	_	_	_	_	_	_	_
20	known	know	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	influence	influence	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	cellular	cellular	_	_	_	_	_	_	_
25	redox	redox	_	_	_	_	_	_	_
26	status	status	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Thiol	Thiol	_	_	_	_	_	_	_
2	modifying	modify	_	_	_	_	_	_	_
3	agents	agent	_	_	_	_	_	_	_
4	like	like	_	_	_	_	_	_	_
5	diamide	diamide	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	menadione	menadione	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
10	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	PDTC	PDTC	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	diethyl	diethyl	_	_	_	_	_	_	_
16	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
17	or	or	_	_	_	_	_	_	_
18	phenylarsine	phenylarsine	_	_	_	_	_	_	_
19	oxide	oxide	_	_	_	_	_	_	_
20	inhibited	inhibit	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	IL-1-induced	il-1-induced	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	IL-1RI-associated	il-1ri-associated	_	_	_	_	_	_	_
27	protein	protein	_	_	_	_	_	_	_
28	kinase	kinase	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	N-Acetylcysteine	N-Acetylcysteine	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	alpha,alphaâ€™-dipyridyl	alpha,alpha'-dipyridyl	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	aminotriazole	aminotriazole	_	_	_	_	_	_	_
6	or	or	_	_	_	_	_	_	_
7	nitrofurantoin	nitrofurantoin	_	_	_	_	_	_	_
8	did	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	show	show	_	_	_	_	_	_	_
11	any	any	_	_	_	_	_	_	_
12	effect	effect	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	by	by	_	_	_	_	_	_	_
4	PDTC	PDTC	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	reversible	reversible	_	_	_	_	_	_	_
7	unless	unless	_	_	_	_	_	_	_
8	glutathione	glutathione	_	_	_	_	_	_	_
9	synthesis	synthesis	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	blocked	block	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	buthionine	buthionine	_	_	_	_	_	_	_
14	sulfoximine	sulfoximine	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	described	describe	_	_	_	_	_	_	_
3	conditions	condition	_	_	_	_	_	_	_
4	which	which	_	_	_	_	_	_	_
5	inhibited	inhibit	_	_	_	_	_	_	_
6	or	or	_	_	_	_	_	_	_
7	prevented	prevent	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	IL-1RI-associated	il-1ri-associated	_	_	_	_	_	_	_
13	kinase	kinase	_	_	_	_	_	_	_
14	similarly	similarly	_	_	_	_	_	_	_
15	impaired	impair	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	NF-kappa	NF-kappa	_	_	_	_	_	_	_
20	B	B	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	EL4	el4	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	From	from	_	_	_	_	_	_	_
2	these	these	_	_	_	_	_	_	_
3	observations	observation	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	conclude	conclude	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	free	free	_	_	_	_	_	_	_
8	thiols	thiol	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	IL-1RI	IL-1RI	_	_	_	_	_	_	_
12	complex	complex	_	_	_	_	_	_	_
13	are	be	_	_	_	_	_	_	_
14	essential	essential	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	IL-1RI-associated	il-1ri-associated	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	kinase	kinase	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	this	this	_	_	_	_	_	_	_
26	process	process	_	_	_	_	_	_	_
27	is	be	_	_	_	_	_	_	_
28	mandatory	mandatory	_	_	_	_	_	_	_
29	for	for	_	_	_	_	_	_	_
30	IL-1	il-1	_	_	_	_	_	_	_
31	signaling	signaling	_	_	_	_	_	_	_
32	leading	lead	_	_	_	_	_	_	_
33	to	to	_	_	_	_	_	_	_
34	NF-kappa	NF-kappa	_	_	_	_	_	_	_
35	B	B	_	_	_	_	_	_	_
36	activation	activation	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

